OncoZenge AB's total assets for Q4 2024 were kr11.43M, a decrease of -16.25% from the previous quarter. DE:8LY total liabilities were kr1.48M for the fiscal quarter, a 23.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.